Surfactant Proteins SP-B and SP-C in Pulmonary Surfactant Monolayers: Physical Properties Controlled by Specific Protein-Lipid Interactions. 2023

Juho Liekkinen, and Agnieszka Olżyńska, and Lukasz Cwiklik, and Jorge Bernardino de la Serna, and Ilpo Vattulainen, and Matti Javanainen
Department of Physics, University of Helsinki, FI-00560 Helsinki, Finland.

The lining of the alveoli is covered by pulmonary surfactant, a complex mixture of surface-active lipids and proteins that enables efficient gas exchange between inhaled air and the circulation. Despite decades of advancements in the study of the pulmonary surfactant, the molecular scale behavior of the surfactant and the inherent role of the number of different lipids and proteins in surfactant behavior are not fully understood. The most important proteins in this complex system are the surfactant proteins SP-B and SP-C. Given this, in this work we performed nonequilibrium all-atom molecular dynamics simulations to study the interplay of SP-B and SP-C with multicomponent lipid monolayers mimicking the pulmonary surfactant in composition. The simulations were complemented by z-scan fluorescence correlation spectroscopy and atomic force microscopy measurements. Our state-of-the-art simulation model reproduces experimental pressure-area isotherms and lateral diffusion coefficients. In agreement with previous research, the inclusion of either SP-B and SP-C increases surface pressure, and our simulations provide a molecular scale explanation for this effect: The proteins display preferential lipid interactions with phosphatidylglycerol, they reside predominantly in the lipid acyl chain region, and they partition into the liquid expanded phase or even induce it in an otherwise packed monolayer. The latter effect is also visible in our atomic force microscopy images. The research done contributes to a better understanding of the roles of specific lipids and proteins in surfactant function, thus helping to develop better synthetic products for surfactant replacement therapy used in the treatment of many fatal lung-related injuries and diseases.

UI MeSH Term Description Entries
D010743 Phospholipids Lipids containing one or more phosphate groups, particularly those derived from either glycerol (phosphoglycerides see GLYCEROPHOSPHOLIPIDS) or sphingosine (SPHINGOLIPIDS). They are polar lipids that are of great importance for the structure and function of cell membranes and are the most abundant of membrane lipids, although not stored in large amounts in the system. Phosphatides,Phospholipid
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D011663 Pulmonary Surfactants Substances and drugs that lower the SURFACE TENSION of the mucoid layer lining the PULMONARY ALVEOLI. Surfactants, Pulmonary,Pulmonary Surfactant,Surfactant, Pulmonary
D013499 Surface Properties Characteristics or attributes of the outer boundaries of objects, including molecules. Properties, Surface,Property, Surface,Surface Property
D013501 Surface-Active Agents Agents that modify interfacial tension of water; usually substances that have one lipophilic and one hydrophilic group in the molecule; includes soaps, detergents, emulsifiers, dispersing and wetting agents, and several groups of antiseptics. Surface Active Agent,Surface-Active Agent,Surfactant,Surfactants,Tenside,Amphiphilic Agents,Surface Active Agents,Tensides,Active Agent, Surface,Active Agents, Surface,Agent, Surface Active,Agent, Surface-Active,Agents, Amphiphilic,Agents, Surface Active,Agents, Surface-Active
D055592 Biophysical Phenomena The physical characteristics and processes of biological systems. Biophysical Concepts,Biophysical Processes,Biophysical Phenomenon,Biophysical Process,Biophysical Concept,Concept, Biophysical,Concepts, Biophysical,Phenomena, Biophysical,Phenomenon, Biophysical,Process, Biophysical,Processes, Biophysical
D037701 Pulmonary Surfactant-Associated Protein B A pulmonary surfactant associated-protein that plays an essential role in alveolar stability by lowering the surface tension at the air-liquid interface. Inherited deficiency of pulmonary surfactant-associated protein B is one cause of RESPIRATORY DISTRESS SYNDROME, NEWBORN. Pulmonary Surfactant-Associated Protein SP-B,SP-B Protein,SP-B Pulmonary Surfactant-Associated Protein,Surfactant Protein SP-B,Pulmonary Surfactant Associated Protein B,Pulmonary Surfactant Associated Protein SP B,SP B Protein,SP B Pulmonary Surfactant Associated Protein,Surfactant Protein SP B
D037721 Pulmonary Surfactant-Associated Protein C A pulmonary surfactant associated protein that plays a role in alveolar stability by lowering the surface tension at the air-liquid interface. It is a membrane-bound protein that constitutes 1-2% of the pulmonary surfactant mass. Pulmonary surfactant-associated protein C is one of the most hydrophobic peptides yet isolated and contains an alpha-helical domain with a central poly-valine segment that binds to phospholipid bilayers. Pulmonary Surfactant-Associated Protein SP-C,Pulmonary Surfactant Protein C,SP-C protein,Surfactant Polypeptide SP-C,Pulmonary Surfactant Associated Protein C,Pulmonary Surfactant Associated Protein SP C,SP C protein,SP-C, Surfactant Polypeptide,Surfactant Polypeptide SP C

Related Publications

Juho Liekkinen, and Agnieszka Olżyńska, and Lukasz Cwiklik, and Jorge Bernardino de la Serna, and Ilpo Vattulainen, and Matti Javanainen
April 1994, Biophysical journal,
Juho Liekkinen, and Agnieszka Olżyńska, and Lukasz Cwiklik, and Jorge Bernardino de la Serna, and Ilpo Vattulainen, and Matti Javanainen
April 1994, Biophysical journal,
Juho Liekkinen, and Agnieszka Olżyńska, and Lukasz Cwiklik, and Jorge Bernardino de la Serna, and Ilpo Vattulainen, and Matti Javanainen
January 2001, Pediatric pathology & molecular medicine,
Juho Liekkinen, and Agnieszka Olżyńska, and Lukasz Cwiklik, and Jorge Bernardino de la Serna, and Ilpo Vattulainen, and Matti Javanainen
April 1994, Biophysical journal,
Juho Liekkinen, and Agnieszka Olżyńska, and Lukasz Cwiklik, and Jorge Bernardino de la Serna, and Ilpo Vattulainen, and Matti Javanainen
January 1994, Seikagaku. The Journal of Japanese Biochemical Society,
Juho Liekkinen, and Agnieszka Olżyńska, and Lukasz Cwiklik, and Jorge Bernardino de la Serna, and Ilpo Vattulainen, and Matti Javanainen
July 2001, Biophysical journal,
Juho Liekkinen, and Agnieszka Olżyńska, and Lukasz Cwiklik, and Jorge Bernardino de la Serna, and Ilpo Vattulainen, and Matti Javanainen
July 1991, American journal of respiratory cell and molecular biology,
Juho Liekkinen, and Agnieszka Olżyńska, and Lukasz Cwiklik, and Jorge Bernardino de la Serna, and Ilpo Vattulainen, and Matti Javanainen
May 1995, Biochimica et biophysica acta,
Juho Liekkinen, and Agnieszka Olżyńska, and Lukasz Cwiklik, and Jorge Bernardino de la Serna, and Ilpo Vattulainen, and Matti Javanainen
July 2000, European journal of medical research,
Juho Liekkinen, and Agnieszka Olżyńska, and Lukasz Cwiklik, and Jorge Bernardino de la Serna, and Ilpo Vattulainen, and Matti Javanainen
June 1996, American journal of respiratory cell and molecular biology,
Copied contents to your clipboard!